CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice

Stefano Fumagalli1, Carlo Perego, Fabrizio Ortolano

  • 1Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy.

Glia
|February 27, 2013
PubMed

Insights

Deleting the fractalkine receptor CX3CR1 reduced brain infarct size in mice after stroke. This CX3CR1 deletion also altered microglia morphology and promoted a protective M2 polarization, suggesting a potential therapeutic target for stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Fractalkine (CX3CL1) and its receptor CX3CR1 play complex roles in neurological disorders.
  • Previous studies on CX3CR1 in neurological conditions have produced conflicting findings.
  • Understanding CX3CR1's role in ischemic stroke is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of CX3CR1 deletion on brain injury following ischemic stroke.
  • To analyze microglia dynamics, morphology, and activation states in the absence of CX3CR1.
  • To determine the effect of CX3CR1 deficiency on microglia/macrophage polarization after stroke.

Main Methods:

  • Used a transient middle cerebral artery occlusion (MCAo) model in mice lacking CX3CR1 (cx3cr1(-/-)) and compared them to wild-type and heterozygous mice.
  • Employed in vivo two-photon microscopy for longitudinal analysis of microglia behavior before and after ischemia.
  • Conducted post-mortem immunohistochemistry to quantify markers of microglia/macrophage activation and polarization.

Main Results:

  • Mice lacking CX3CR1 exhibited significantly smaller brain infarct volumes compared to control groups.
  • CX3CR1 deficiency altered microglia morphology, with fewer hypertrophic/amoeboid forms observed.
  • Post-ischemic analysis revealed decreased markers of M/M activation (CD11b, CD68) and M1 polarization (iNOS), alongside increased M2 polarization markers (Ym1) and leukocyte recruitment (CD45high) in cx3cr1(-/-) mice.

Conclusions:

  • CX3CR1 deletion confers protection against ischemic brain injury in the early stages post-stroke.
  • The protective effect is associated with altered microglia morphology and a shift towards an anti-inflammatory M2 polarization profile.
  • Targeting the CX3CR1 pathway may represent a novel therapeutic strategy for mitigating ischemic stroke damage.

Related Concept Videos